QM · rank #18 · 2026-09-08
EXENS
PARIS · EUR · $3.32B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +60.26% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +6.0% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $3.32B |
| Anchor (recent) Close on 2026-08-07 | $63.25 |
| Anchor (far) Close on 2025-08-08 | $39.47 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens is a Paris-listed photonics and optoelectronics company supplying mission-critical night-vision tubes, thermal cameras, and imaging solutions primarily to defense and surveillance customers across Europe and North America.
Rationale
The 60% trailing momentum is directly supported by fundamental delivery — 15.3% H1 2026 revenue growth, ~33% EBITDA margins, guidance raised to upper end, EIB financing secured, and named multi-year defense contracts (BiNOD, ACTinBlack) providing revenue visibility that validates quality screens alongside the price signal.
Material risks
- 1Defense procurement cycle disruption — specifically, a U.S. budget continuing resolution or NDAA cut could delay or reduce BiNOD IDIQ call-offs, which are a key growth driver priced into current momentum.
- 2Export control tightening on dual-use night-vision and photonics technology could restrict international sales and impair the return on EIB-funded capacity expansion before it is fully absorbed.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.